Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |